Hélène D'Anjou is currently the Director of Analysis and Evaluation at Axelys, where they are responsible for leading evaluation initiatives. Prior to this role, Hélène worked as a Technology Analyst in Life Sciences at Aligo Innovation from 2016 to 2021 and served as a Consultant at Socpra in 2015. From 2003 to 2011, Hélène gained experience as a Research Scientist at Topigen Pharmaceuticals/Pharmaxis. Hélène holds a PhD in Molecular Biology from Université de Montréal, a BSc in Biochemistry from Université du Québec à Trois-Rivières, and a microprogram in Technology Transfer from Université de Sherbrooke, supplemented by coursework at McGill University in patent understanding.
This person is not in the org chart
This person is not in any teams
This person is not in any offices